|
Volumn 80, Issue 2, 1994, Pages 284-297
|
Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain: Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml
a a a a |
Author keywords
Analgesics, opioid: morphine; Anesthetic techniques: spinal; Anesthetics, local: bupivacaine; Pain, cancer: antinociception
|
Indexed keywords
BUPIVACAINE;
MORPHINE;
ADULT;
AGED;
ANALGESIA;
ANESTHESIA MECHANISM;
ARTICLE;
CANCER PAIN;
CLINICAL TRIAL;
CLONUS;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG USE;
FEMALE;
GAIT;
HUMAN;
INTRATHECAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
ORTHOSTATIC HYPOTENSION;
PARESTHESIA;
PRIORITY JOURNAL;
SEDATION;
SEIZURE;
SLEEP;
URINE RETENTION;
VISCERAL PAIN;
|
EID: 0028008767
PISSN: 00033022
EISSN: None
Source Type: Journal
DOI: 10.1097/00000542-199402000-00008 Document Type: Article |
Times cited : (111)
|
References (0)
|